Gene Expression Profiling for Molecular Features of Response in a Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas

被引：0

作者：

Fanale, Michelle A. ^{[1
]}

Wang, Zhiqiang ^{[1
]}

Ma, Wencai ^{[1
]}

Oki, Yasuhiro ^{[1
]}

Hagemeister, Fredrick B. ^{[1
]}

Fayad, Luis E. ^{[1
]}

Fowler, Nathan ^{[1
]}

Romaguera, Jorge E. ^{[1
]}

Shah, Nina ^{[2
]}

Chuang, Hubert H. ^{[3
]}

Lei, Feng ^{[4
]}

Horowitz, Sandra B. ^{[5
]}

Chihara, Dai ^{[1
]}

Wesson, Emily ^{[1
]}

Hutto, Toni Y. ^{[1
]}

Ruben, Charnelle ^{[1
]}

Samaniego, Felipe ^{[1
]}

Muzzafar, Tariq ^{[6
]}

Piekarz, Richard ^{[7
]}

Davis, R. Eric ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Pharm, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[7] NCI, Canc Therapeut Evaluat Program, Bethesda, MD 20892 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) plus Rituximab ± Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas
Kelly, Kevin R.
Persky, Daniel O.
Mahadevan, Daruka
Miller, Thomas P.
Puvvada, Soham D.
McDonagh, Kevin
Hayslip, John
Park, Steven I.
Ruan, Jia
Rosen, Peter J.
Iyer, Swaminathan Padmanabhan
Stefanovic, Alexandra
Zhang, Bin
Zhou, Xiaofei
Ullmann, Claudio Dansky
Leonard, E. Jane
Friedberg, Jonathan W.
BLOOD, 2013, 122 (21)
[22] Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108
Barr, Paul M.
Li, Hongli
Spier, Catherine
Mahadevan, Daruka
LeBlanc, Michael
Haq, Mansoor Ul
Huber, Bryan D.
Flowers, Christopher R.
Wagner-Johnston, Nina D.
Horwitz, Steven M.
Fisher, Richard I.
Cheson, Bruce D.
Smith, Sonali M.
Kahl, Brad S.
Bartlett, Nancy L.
Friedberg, Jonathan W.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (21) : 2399 - U105
[23] RITUXIMAB, BENDAMUSTINE AND CYTARABINE (R-BAC) IN PATIENTS WITH RELAPSED-REFRACTORY AGGRESSIVE B- AND T-CELL LYMPHOMA
Tisi, M. C.
Paolini, R.
Piazza, F.
Ravelli, E.
Carli, G.
Perbellini, O.
Ruggeri, M.
Visco, C.
HAEMATOLOGICA, 2017, 102 : 51 - 51
[24] A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell Lymphomas
Rutherford, Sarah C.
Allan, John N.
Ruan, Jia
Furman, Richard R.
Richards, Kristy
Rodriguez, Amelyn
Gololobova, Kseniya
Garcia, Arcania
Cerchietti, Leandro
Marullo, Rossella
Chen, Zhengming
Santamala, Jennifer
Shore, Tsiporah B.
Phillips, Adrienne A.
Mayer, Sebastian
Hsu, Jingmei
Gergis, Usama
Senese, Silvia
Ali-Shaw, Trisha
Rahim, Riyaad
van Besien, Koen
Leonard, John P.
Martin, Peter
BLOOD, 2020, 136
[25] Phase I Study of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Chihara, Dai
Oki, Yasuhiro
Fayad, Luis
Wesson, Emily
Ruben, Charnelle
Horowitz, Sandra B.
Woolery, Joseph
Feng, Lei
Garg, Naveen
Ahmed, Sairah
Khouri, Issa F.
Fanale, Michelle A.
BLOOD, 2014, 124 (21)
[26] A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
Cinzia Pellegrini
Anna Dodero
Annalisa Chiappella
Federico Monaco
Debora Degl’Innocenti
Flavia Salvi
Umberto Vitolo
Lisa Argnani
Paolo Corradini
Pier Luigi Zinzani
Journal of Hematology & Oncology, 9
[27] A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
Pellegrini, Cinzia
Dodero, Anna
Chiappella, Annalisa
Monaco, Federico
Degl'Innocenti, Debora
Salvi, Flavia
Vitolo, Umberto
Argnani, Lisa
Corradini, Paolo
Zinzani, Pier Luigi
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[28] Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
Ballester, B
Gisselbrecht, C
Gaulard, P
Houlgatte, R
Xerri, L
ANNALS OF ONCOLOGY, 2005, 16 : 74 - 74
[29] Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
B Ballester
O Ramuz
C Gisselbrecht
G Doucet
L Loï
B Loriod
F Bertucci
R Bouabdallah
E Devilard
N Carbuccia
M-J Mozziconacci
D Birnbaum
P Brousset
F Berger
G Salles
J Briére
R Houlgatte
P Gaulard
L Xerri
Oncogene, 2006, 25 : 1560 - 1570
[30] Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
Ballester, B
Ramuz, O
Gisselbrecht, C
Doucet, G
Loï, L
Loriod, B
Bertucci, F
Bouabdallah, R
Devilard, E
Carbuccia, N
Mozziconacci, MJ
Birnbaum, D
Brousset, P
Berger, F
Salles, G
Briére, J
Houlgatte, R
Gaulard, P
Xerri, L
ONCOGENE, 2006, 25 (10) : 1560 - 1570

← 1 2 3 4 5 →